{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-016900","form_type":"8-K","ticker":"SIGA","cik":"0001010086","company_name":"SIGA TECHNOLOGIES INC","filed_at":"2024-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:16.861278+00:00","generated_at":"2026-06-04T04:18:38.754068+00:00","sec_items":["1.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"SIGA assumes primary responsibility for oral TPOXX promotion; Meridian retains limited rights in EU/UK/AU/JP/CH","bullets":["Amendment to Promotion Agreement effective June 1, 2024; SIGA takes over global advertising, promotion and sale of oral TPOXX.","Meridian retains non-exclusive rights only in European Economic Area, Australia, Japan, Switzerland and the UK.","Meridian receives reduced promotion fee: high single-digit percentage of collected proceeds from Territory sales.","Agreement has fixed term expiring May 31, 2026, with no automatic renewal."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-016900","json":"https://secwatch.observer/filing/0001140361-24-016900.json","markdown":"https://secwatch.observer/filing/0001140361-24-016900.md","text":"https://secwatch.observer/filing/0001140361-24-016900.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124016900/0001140361-24-016900-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124016900/ef20025678_form8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-04T04:18:38.754068+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c37aee14f2c956cbf872ca2a5a3d9886e74babc2","claim":"SIGA TECHNOLOGIES INC amended Amendment with Meridian Medical Technologies, LLC (effective 2024-03-27).","evidence_excerpt":"On March 27, 2024, SIGA Technologies, Inc. (the “Company”) and Meridian Medical Technologies, LLC (“Meridian”) entered into an amendment (the “Amendment”) to the Promotion Agreement","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1010086/000114036124016900/0001140361-24-016900-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Counterparty","value":"Meridian Medical Technologies, LLC"},{"label":"Effective","value":"2024-03-27"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}